Maxillary osteonecrosis associated to antiangiogenic drugs

被引:10
作者
Salort-Llorca, Cesar
Minguez-Serra, Mari-Paz [1 ]
Silvestre-Donat, Francisco-Javier [1 ,2 ]
机构
[1] Doctor Peset Univ Hosp, Stomatol Unit, Valencia, Spain
[2] Univ Valencia, Med & Dent School, Dept Stomatol, Valencia, Spain
来源
MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL | 2011年 / 16卷 / 02期
关键词
JAW; BISPHOSPHONATE; BEVACIZUMAB; AGENTS;
D O I
10.4317/medoral.16.e137
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
引用
收藏
页码:E137 / E138
页数:2
相关论文
共 10 条
[1]   The Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaw: So Many Hypotheses, So Few Data [J].
Allen, Matthew R. ;
Burr, David B. .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2009, 67 (05) :61-70
[2]   Osteonecrosis of the Jaw and the Use of Antiangiogenic Agents: Just an Association? [J].
Aragon-Ching, Jeanny B. ;
Dahut, William L. .
ONCOLOGIST, 2008, 13 (12) :1314-1314
[3]   Higher Incidence of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Anti-Angiogenic Agents [J].
Aragon-Ching, Jeanny B. ;
Ning, Yang-Min ;
Chen, Clara C. ;
Latham, Lea ;
Guadagnini, Jean-Pierre ;
Gulley, James L. ;
Arlen, Philip M. ;
Wright, John J. ;
Parnes, Howard ;
Figg, William D. ;
Dahut, William L. .
CANCER INVESTIGATION, 2009, 27 (02) :221-226
[4]   Osteonecrosis of the jaw under bisphosphonate and antiangiogenic therapies: cumulative toxicity profile? [J].
Ayllon, J. ;
Launay-Vacher, V. ;
Medioni, J. ;
Cros, C. ;
Spano, J. P. ;
Oudard, S. .
ANNALS OF ONCOLOGY, 2009, 20 (03) :600-601
[5]  
Bagan Jose, 2007, Med Oral Patol Oral Cir Bucal, V12, pE336
[6]   Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update [J].
Bagan, Jose ;
Scully, Crispian ;
Sabater, Vicente ;
Jimenez, Yolanda .
ORAL ONCOLOGY, 2009, 45 (07) :551-554
[7]   Worsening of osteonecrosis of the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinoma [J].
Brunello, Antonella ;
Saia, Giorgia ;
Bedogni, Alberto ;
Scaglione, Daniela ;
Basso, Umberto .
BONE, 2009, 44 (01) :173-175
[8]   Combination of Bisphosphonates and Antiangiogenic Factors Induces Osteonecrosis of the Jaw More Frequently than Bisphosphonates Alone [J].
Christodoulou, C. ;
Pervena, A. ;
Klouvas, G. ;
Galani, E. ;
Falagas, M. E. ;
Tsakalos, G. ;
Visvikis, A. ;
Nikolakopoulou, A. ;
Acholos, V. ;
Karapanagiotidis, G. ;
Batziou, E. ;
Skarlos, D. V. .
ONCOLOGY, 2009, 76 (03) :209-211
[9]   Osteonecrosis of the jaw related to bevacizumab [J].
Estilo, Cherry L. ;
Fornier, Monica ;
Farooki, Azeez ;
Carlson, Diane ;
Bohle, George, III ;
Huryn, Joseph M. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (24) :4037-4038
[10]   Bevacizumab-associated osteonecrosis of the jaw [J].
Greuter, S. ;
Schmid, F. ;
Ruhstaller, T. ;
Thuerlimann, B. .
ANNALS OF ONCOLOGY, 2008, 19 (12) :2091-U3